P5L (p.Pro5Leu) variant of TOP2A (DNA topoisomerase 2-alpha)

P5L (p.Pro5Leu) in TOP2A (DNA topoisomerase 2-alpha) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

P5L (p.Pro5Leu) variant details